A61P 31/18
For hiv
Official title: for HIV
A61P31/18 (For hiv) appears on 10,752 US grants and 15,725 published applications in this corpus.
Search patents in A61P- Granted patents
- 10,752
- Published applications
- 15,725
- Assignees
- 4,220
- Inventors
- 24,448
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 12 | 0 |
| 1991 | 18 | 0 |
| 1992 | 17 | 0 |
| 1993 | 22 | 0 |
| 1994 | 16 | 0 |
| 1995 | 30 | 0 |
| 1996 | 73 | 0 |
| 1997 | 112 | 0 |
| 1998 | 156 | 0 |
| 1999 | 188 | 0 |
| 2000 | 230 | 0 |
| 2001 | 272 | 73 |
| 2002 | 276 | 392 |
| 2003 | 322 | 695 |
| 2004 | 244 | 860 |
| 2005 | 244 | 829 |
| 2006 | 346 | 802 |
| 2007 | 355 | 834 |
| 2008 | 372 | 870 |
| 2009 | 479 | 978 |
| 2010 | 616 | 1141 |
| 2011 | 567 | 1011 |
| 2012 | 667 | 912 |
| 2013 | 631 | 673 |
| 2014 | 674 | 731 |
| 2015 | 530 | 604 |
| 2016 | 463 | 582 |
| 2017 | 484 | 566 |
| 2018 | 418 | 557 |
| 2019 | 406 | 527 |
| 2020 | 352 | 457 |
| 2021 | 308 | 403 |
| 2022 | 241 | 321 |
| 2023 | 184 | 294 |
| 2024 | 174 | 266 |
| 2025 | 150 | 216 |
| 2026 | 97 | 131 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Conjugates of guide RNA-Cas protein complex22 Sep 2026US 12,742,162 B2
- Method of treating viral infections with hexose type monosaccharides and analogs thereof15 Sep 2026US 12,734,185 B2Board of Regents, The University of Texas System
- Treatment of immunosuppressed subjects15 Sep 2026US 12,734,216 B2NantCell, Inc.
- Compounds for the treatment of human immunodeficiency virus8 Sep 2026US 12,729,194 B2Dana-Farber Cancer Institute, Inc.
- HIV immunotherapy with no pre-immunization step18 Aug 2026US 12,709,753 B2American Gene Technologies International Inc.
- Improved alum-anchored immunogens1 Oct 2026US 2026/0295039 A1Massachusetts Institute of Technology
- Methods and compositions including protocatechuic acid crystals for the treatment of conditions caused by an enveloped virus24 Sep 2026US 2026/0283989 A1
- Hiv vaccine24 Sep 2026US 2026/0284176 A1
- Hiv-1p rotease inhibitors and uses thereof17 Sep 2026US 2026/0272926 A1Purdue Research Foundation
- Bridged tricyclic carbamoylpyridone compounds and uses thereof17 Sep 2026US 2026/0272961 A1Gilead Sciences, Inc.
Most cited
By later US patents
- Modular infusion device and method1,554US 6,749,587 B2Insulet Corporation · 2004
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Process for preparing diaminophenothiazinium compounds687US 8,765,942 B2Provence Technologies · 2014
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003
- Human monoclonal antibodies to programmed death ligand 1 (PD-L1)628US 7,943,743 B2Medarex, Inc. · 2011